Janus Global Life Sciences Fund

4 / 5 Stars
5 5 5 3 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
A+ (Buy)

#1 in Health

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Janus funds

See full Health rankings

See more fund rankings


The fund has returned 62.83 percent over the past year, 31.62 percent over the past three years, 29.17 percent over the past five years, and 12.64 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 14.5%
1 Year 62.8%
3 Years (Annualized) 31.6%
5 Years (Annualized) 29.2%
10 Years (Annualized) 12.6%

See more JFNAX performance


The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.


Fees are Low compared to funds in the same category.
Janus Global Life Sciences Fund has an expense ratio of 1.04 percent.

See more JFNAX fees


Risk is Average compared to funds in the same category according to Morningstar.

See more JFNAX risk